INS and hydrops fetalis: In this double-blind, randomized, multicenter research, participants received pioglitazone or glyburide (insulin) for six months. Time to HF, a composite of cardiovascular mortality and hospitalization or ER visit for HF, was the main outcome. Echocardiographic and functional categorization tests were secondary objectives.